Back Understanding Autoimmune Disease
Understanding Autoimmune Disease
Back Resources for Hope and Health
Resources for Hope and Health
Back Autoimmune Research & News
Autoimmune Research & News
Back Who We Are & How We Help
Who We Are & How We Help
an icon of a microscope, indicating research and science
Research Grants
& Projects

New Study Tracks Post-COVID Illness and New-Onset Diseases

A prospective study from India followed COVID-19 patients for 16 weeks and found that over half developed post-COVID-19 syndrome (PCS), and more than one in four developed new diseases or symptoms that hadn’t been present during their acute infection.

Researchers at a post-COVID clinic in New Delhi followed 95 patients who had confirmed SARS-CoV-2 infection.

Based on NICE guidelines, participants were classified into:

  • Acute COVID-19: symptoms ≤4 weeks
  • Ongoing symptomatic COVID-19: symptoms 4–12 weeks
  • Post-COVID syndrome (PCS): symptoms >12 weeks

Key findings:

  • 51.6% of patients developed PCS
  • Fatigue (62%), breathlessness (50%), and cough (27%) were the most common lingering symptoms
  • 26.3% developed new-onset diseases or symptoms, including:
    • Rheumatoid arthritis
    • Hypertension, diabetes
    • Pulmonary fibrosis, thromboembolism
    • Sinus tachycardia, obstructive airway disease
    • Tuberculosis reactivation
    • Psychiatric conditions like psychosis and depression

Patients with PCS had significantly worse health scores than those who recovered earlier. Risk factors for developing PCS included severe COVID-19, longer hospital stay, higher white blood cell count, and prolonged steroid use.

This study adds to growing evidence that COVID-19 may trigger new-onset autoimmune conditions, including rheumatoid arthritis. For people already living with autoimmune or immune-mediated disease, this raises several concerns:

  • Post-COVID flares or new symptoms may be dismissed or misdiagnosed
  • New autoimmune conditions may emerge after infection, especially in those with genetic susceptibility
  • Long COVID symptoms can overlap with autoimmune fatigue, breathlessness, and inflammation, making a clear diagnosis harder

The findings support the need for long-term follow-up care after COVID-19, particularly for those with existing immune conditions or high inflammatory responses during infection.

Citation

Sinha, N., et al. (2025). Post COVID-19 syndrome and new onset diseases: a prospective observational study. Singapore medical journal, 66(7), 354–361. https://doi.org/10.4103/singaporemedj.SMJ-2022-055